Comparison of Algorithms for the Closed-Loop Control of Blood Glucose Using the Artificial Beta Cell

IEEE Transactions on Biomedical Engineering

Volumn BME-28, Issue 10, 1981, Pages 678-687

  Broekhuyse, Henry M ^a   Nelson, Jill D ^b   Zinman, Bernard ^c   Albisser, A M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Shaughnessy Hospital   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER PROGRAMMING - SUBROUTINES;

BLOOD-GLUCOSE MONITORING; INSULIN INFUSION;

BIOMEDICAL ENGINEERING;

INSULIN;

ALGORITHM; ARTIFICIAL PANCREAS; COMPUTER ANALYSIS; COMPUTER SIMULATION; DIABETES MELLITUS; ENDOCRINE SYSTEM; GLUCOSE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; THEORETICAL STUDY; THERAPY;

ARTIFICIAL ORGANS; BLOOD GLUCOSE; HUMAN; ISLETS OF LANGERHANS; MATHEMATICS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0019728673     PISSN: 00189294     EISSN: 15582531     Source Type: Journal    
DOI: 10.1109/TBME.1981.324661     Document Type: Article

References (29)

1. A. M. Albisser, “Devices for the control of diabetes mellitus,” Proc. IEEE, vol. 67, pp. 1308–1320, 1979.
2. A. M. Albisser, B. S. Leibel, T. G. Ewart, Z. Davidovac, C. K. Botz, and W. Zingg, “An artificial endocrine pancreas,” Diabetes, vol. 23, pp. 389–396, 1974.
3. A. M. Albisser, B. S. Leibel, T. G. Ewart, Z. Davidovac, C. K. Botz, W. Zingg, H. Schipper, and R. Gander, “Clinical control of diabetes by the artificial pancreas,” Diabetes, vol. 23, pp. 397– 404, 1974.
4. A. M. Albisser, C. K. Botz, and B. S. Leibel, “Blood glucose regulation using an open-loop insulin delivery system in pancreatectomized dogs given glucose infusions. I. Portal square waves,” Diabetolog., vol. 16, pp. 129–133, 1979.
5. A. M. Albisser, J. Ellman, A. Hanna, Y. Goriya, and H. Minuk, “Continuous blood glucose analysis in vitro and in vivo,” Diabetolog.,vol. 15, pp. 303–308, 1978.
6. A. M. Albisser, B. S. Leibel, W. Johnson, A. Denoga, C. K. Botz, and E. B. Marliss, “An improved technique for rapid continuous measurement of whole blood glucose, suitable for clinical application in an artificial endocrine pancreas,” Med. Progr. Technol., vol. 5, pp. 141–148, 1977.
7. Biostator (R) Glucose Controlled Insulin Infusion System, Operating Manual, Miles Lab. Inc., 1976.
8. C.K. Botz, “An improved control algorithm for an artificial B-cell,” IEEE Trans. Biomed. Eng., vol. BME-23, pp. 252–255,1976.
9. C. K. Botz, E. B. Marliss, and A. M. Albisser, “Blood glucose regulation using closed- and open-loop insulin delivery systems. II. Peripheral primed square wave infusions,” Diabetolog., vol. 17, pp. 45–49, 1979.
10. A. H. Clemens and P. H. Chang, “Continuous blood glucose analysis and feedback control dynamics for glucose controlled insulin infusion (artificial beta-cell),” in Proc. 14th Int. Congr. Therapeutics, L'Extension Scientifique, 1977, pp. 45–58.
11. A. H. Clemens, P. H. Chang, and R. W. Myers, “The development of Biostator, a glucose controlled insulin infusion system (GCIIS),” Harm. Metab. Res. Suppl., vol. 7, pp. 22–23, 1977.
12. A. H. Clemens, “Feedback control dynamics for glucose controlled insulin infusion system,” Med. Progr. Techno!., vol. 6, pp. 91–98, 1979.
13. D. L. Curry, L. L. Bennett, and G. M. Grodsky, “Dynamics of insulin secretion by the perfused rat pancreas,” Endocrinology, vol. 83, pp. 572–584, 1968.
14. U. Fischer, E. Jutzi, E. J. Freyse, and E. Salzsieder, “Derivation and experimental proof of a new algorithm for the artificial B-cell based on the individual analysis of the physiological insulin-glucose relationship,” Endokrinologie, vol. 71, pp. 65–75, 1978.
15. U. Fischer, E. Jutzi, H. Bombor, E. -J. Freyse, E. Salzsieder, G. Albrecht, W. Besch, and W. Bruns, “Assessment of an algorithm for the artificial B-cell using the normal insulin glucose relationship in diabetic dogs and man,” Diabetolog., vol. 18, pp. 97–107, 1980.
16. Y. Goriya, A. Bahoric, E. B. Marliss, B. Zinman, and A. M. Albisser, “Glycemic regulation using a programmed insulin delivery device. III. Long-term studies on diabetic dogs,” Diabetes, vol. 28, pp. 558–564, 1979.
17. —, “The metabolic and hormonal responses to a mixed meal in unrestrained pancreatectomised dogs chronically treated by portal or peripheral insulin infusion,” Diabetolog., vol. 19, 1981.
18. G. M. Grodsky, L. L. Bennett, D. Smith, and K. Nemechek, “The effect of tolbutamide and glucose on the timed release of insulin from the isolated rat pancreas,” in Tolbutamide after Ten Years, W. J. H. Butterfield and W. Van Westering, II, Eds. New York, 1967.
19. A. H. Kadish, “Automatic control of blood sugar. I. A servo-mechanism for glucose monitoring and control,” Amer. J. Med. Electron., vol 3, pp. 82–86, 1964.
20. R. Kawamori, M. Shichiri, Y. Goriya, Y. Yamasaki, Y. Shigeta, and H. Abe, “Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell,” Acta Endocrinol., vol. 87, pp. 339–351,1978.
21. W. Kerner, Ch. Thum, Gy. Tamas, Jr., W. Beischer, A. H. Clemens, E. F. Pfeiffer, “Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell,” Horm. Metab. Res., vol. 8, pp. 256–261, 1976.
22. E. W. Kraegen, L. V. Campbell, Y. O. Chia, H. Meier, and L. Lazarus, “Control of blood glucose in diabetics using an artificial pancreas,”; Aust. N. Z. J. Med., vol. 7, pp. 280–286, 1977.
23. J. Kudlow, A. M. Albisser, A. Angel, B. Langer, C. Yip, B. Zinman, and E. Stokes, “Insulinoma resection facilitated by the artificial endocrine pancreas,” Diabetes, vol. 27, pp. 774–777, 1978.
24. E. B. Marliss, F. T. Murray, E. F. Stokes, B. Zinman, A. F. Nak-hooda, A. Denoga, B. S. Leibel, and A. M. Albisser, “Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas,” Diabetes, vol. 26, pp. 663–672, 1977.
25. E. F. Pfeiffer, Ch. Thum, and A. H. Clemens, “The artificial beta cell-A continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system),” Horm. Metab. Res., vol. 6, pp. 339–342, 1974.
26. R. A. Rizza, J. E. Gerich, M. W. Haymond, R. E. Westland, L. D. Hall, A. H. Clemens, and F. J. Service, “Control of blood sugar in insulin-dependent diabetes: Comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy,” New Eng. J. Med., vol. 303, pp. 1313–1317, 1980.
27. J. Schlichtkrull, O. Munck, and M. Jersild, “The M-value, an index of blood-sugar control in diabetics,” Acta Med. Scand., vol. 177, pp. 95–102, 1965.
28. H. S. Seltzer, E. W. Allen, A. L. Herron, and M. T. Brennan, “Insulin secretion in response to glycemic stimulus: Relation of delayed insulin release to carbohydrate intolerance in mild diabetes mellitus,” J Clin. Invest., vol. 46, pp. 323–335, 1967.
29. F. J. Service, G. D. Molnar, J. W. Rosevear, E. Akerman, L. C. Gatewood, and W. F. Taylor, “Mean amplitude of glycemie excursions, a measure of diabetic instability,” Diabetes, vol. 19, pp. 644–655, 1970.